January 2019 // Funding

Synendos Therapeutics was successful in winning BaseLaunch competition (Phase II) and was awarded with CHF 250’000. This program enables the company generating critical scientific data and further developing of the business.


https://www.baselaunch.ch/program/

© 2019 Synendos Therapeutics, Inc. All Rights Reserved.

  • LinkedIn - cerchio grigio
  • Twitter - cerchio grigio